To assess the biological significance of TFAP2α expression in bladder tumors, we evaluated the expression using a TMA containing tumors from 282 patients with advanced bladder cancer with full clinical annotation (Table 1). The gene discussed is TFAP2A; the disease is urinary bladder carcinoma.